All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Learn about treatment options, treatment failure, associated adverse effects and more.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Leveraging Pharmacist Expertise in Oral Anticoagulant Reversal

A Virtual Satellite Symposium conducted at the 2020 ASHP Midyear Clinical Meeting and Exhibition

Monday, December 7, 2020, 8:00 AM - 9:30 AM ET
  -  Register to attend December 7



Activity Description

This activity will address the burden of major bleeding for patients on oral anticoagulants and the health-systems that treat them. Principles of reversal agent stewardship will be shared along with methods for creating or supplementing institutional policies with prescribers and other key stakeholders. Learners will be exposed to best practices in dosing and administration in special patient populations, along with variables that may influence restarting anticoagulation after a major bleeding event.

Learning Objectives

The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:

  • Describe risk stratification and the clinical burden of acute major bleeding.
  • Discuss the importance of involving the multidisciplinary team in institutional policy development for reversal agents.
  • Examine administration, dosing, and monitoring of anticoagulant reversal agents in special populations.
  • Outline variables to consider when restarting anticoagulation after an acute major bleeding event.


Tyree H. Kiser, Pharm.D., FCCM, FCCP, BCPS
Professor, Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Anschutz Medical Campus
Critical Care Pharmacy Specialist, University of Colorado Hospital
Aurora, Colorado

Jessica Rimsans, PharmD, BCPS
Clinical Pharmacy Specialist
Hemostatic and Antithrombotic Stewardship
Brigham and Women’s Hospital, Department of Pharmacy Services
Boston, Massachusetts

John Fanikos, RPh, MBA

Executive Director of Pharmacy Services
Brigham and Women’s Hospital
Boston, Massachusetts

CE Accreditation


Pro CE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-20-501-L01-P has been assigned to this live knowledge-based activity (initial release date 12-07-20). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation no later than January 8, 2021 to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Faculty conflict of interest will be announced prior to the start of the CE activity.


This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.


Preregistration is for planning purposes only and virtual attendance will be available on a first-come, first-served basis.    

Webinar Equipment Requirements
-Computer with broadband Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
Click here for detailed software requirements.

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.